Skip to main content

Profound Medical Corp.

PROF
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0001628808

No open-market purchases or sales by Profound Medical Corp. insiders were filed in the last 90 days; 55 institutions reported holding it in 13F filings for Q2 2026, worth $105.8M in total; no superinvestor holds it.

Q2 2022 vs. Q1 2022

How the institutions holding Profound Medical Corp. changed between Q1 2022 and Q2 2022.

All holders in Q2 2022All holders in Q1 2022

13F holders of PROF: Q1 2022 compared with Q2 2022
MeasureQ1 2022Of which not filed for Q2 2022Q2 2022Change
Holders44239−3
Shares9.40M291.7K8.68M−434.7K (−4.8%)
Value$84.6M$2.63M$63.0M−$19.0M (−23.1%)

2 institutions that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so the changes leave them out.

New holders (4)

Institutions that held Profound Medical Corp. at the end of Q2 2022 but not at the end of Q1 2022.

Institutions new to PROF in Q2 2022
InstitutionSharesValue% of portfolio
Crestwood Advisors Group LLC17,700$129.0K0.00%
Cetera Advisor Networks LLC10,519$77.0K0.00%
Credit Suisse AG400$3.00K0.00%
UBS Group AG205$1.00K0.00%

Sold out (7)

Institutions that held Profound Medical Corp. at the end of Q1 2022 and filed for Q2 2022 without it.

Institutions that sold out of PROF in Q2 2022
InstitutionShares, Q1 2022Value, Q1 2022
Altium Capital Management LP124,945$1.13M
Taylor Wealth Management Partners107,381$966.0K
Wealth Management Partners, LLC26,000$230.0K
D. E. Shaw & Co., Inc.22,148$199.0K
Jane Street Group, LLC14,747$132.0K
Optiver Holding B.V.1,227$11.0K
Aquatic Capital Management LLC200$2.00K

Not filed for Q2 2022 yet (2)

Institutions that held Profound Medical Corp. at the end of Q1 2022 and haven't filed a 13F for Q2 2022. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding PROF in Q1 2022 that haven't filed for Q2 2022
InstitutionShares, Q1 2022Value, Q1 2022
Blackcrane Capital, LLC255,292$2.30M
Golden State Equity Partners36,430$328.0K